BINDING OF RIFAMPICIN BY HUMAN PLASMA-PROTEINS

被引:76
作者
BOMAN, G
RINGBERGER, VA
机构
[1] HUDDINGE HOSP, DEPT CLIN PHARMACOL, STOCKHOLM, SWEDEN
[2] KAROLINSKA SJUKHUSET, THORAX MED KLIN, S-10401 STOCKHOLM 60, SWEDEN
关键词
D O I
10.1007/BF00558209
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:369 / 373
页数:5
相关论文
共 24 条
[1]  
AOYAGI T, 1973, SCAND J RESPIR DIS, P44
[2]  
BEEUWKES H, 1969, ARZNEI-FORSCHUNG, V19, P1283
[3]  
BINDA G, 1971, ARZNEI-FORSCHUNG, V21, P1907
[4]   RIFAMPICIN IN PLASMA AND PLEURAL FLUID AFTER SINGLE ORAL DOSES [J].
BOMAN, G ;
MALMBORG, AS .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (01) :51-58
[5]  
BOMAN G, 1971, LANCET, V1, P800
[6]   SERUM CONCENTRATION AND HALF-LIFE OF RIFAMPICIN AFTER SIMULTANEOUS ORAL-ADMINISTRATION OF AMINOSALICYLIC ACID OR ISONIAZID [J].
BOMAN, G .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (03) :217-225
[7]  
BOMAN G, 1973, Scandinavian Journal of Respiratory Diseases Supplementum, V84, P40
[8]   SPECIES DIFFERENCES IN PLASMA PROTEIN BINDING OF DESIPRAMINE [J].
BORGA, O ;
AZARNOFF, DL ;
SJOQVIST, F .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1968, 20 (07) :571-&
[9]   SPECIES DIFFERENCES IN BINDING OF PHENYLBUTAZONE TO PLASMA ALBUMIN [J].
CHIGNELL, CF ;
STARKWEATHER, DK .
PHARMACOLOGY, 1971, 5 (04) :235-+
[10]  
CURCI G, 1968, 19 C IT TIS PARM SAL, V3, P955